Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

0.7907 +0.0208 (+2.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biolinerx Ltd ADR

< Previous 1 2 3 4 Next >
Finns and Danes
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Chiasma (NASDAQ:CHMA) shares moved upwards by 41.9% to $4.03 during Wednesday's regular session. Chiasma's stock is trading at a volume of 75.5 million... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Chiasma (NASDAQ:CHMA) stock moved upwards by 39.04% to $3.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $228.4... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5... 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors. Chiasma, Inc. (NASDAQ: CHMA) gained 53... 
Via Benzinga
Merry Month of May
Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened. 
Via Talk Markets
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Obalon Therapeutics (NASDAQ:OBLN)... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; Neuronetics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 34,036.73 while the NASDAQ fell 2.2% to 13,589.88. The S&P also fell, dropping 1.06% to 4,148.42. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today
Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc. (NASDAQ: STIM) and BioLineRx Ltd. (NASDAQ: BLRX) are among the biggest health care... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Cocrystal Pharma (NASDAQ:COCP) stock rose 143.41% to $3.02 during Tuesday's regular session. Trading volume for Cocrystal Pharma's stock is 378.0 million... 
Via Benzinga
Mid-Day Market Update: Maxar Technologies Falls After Q1 Results; BioLineRx Shares Climb
Midway through trading Tuesday, the Dow traded down 0.93% to 33,796.93 while the NASDAQ fell 2.6% to 13,530.71. The S&P also fell, dropping 1.4% to 4,134.15. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target... 
Via Benzinga
Exposures COVID-19
Mid-Morning Market Update: Markets Open Lower; Pfizer Raises FY21 Outlook
Following the market opening Tuesday, the Dow traded down 0.58% to 33,914.95 while the NASDAQ fell 1.94% to 13,625.24. The S&P also fell, dropping 0.95% to 4,152.79. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
BioLineRx Stock Is Trading Higher As Motixafortide-G-CSF Combo Shows Promise In Transplant Setting For Multiple Myeloma Patients
BioLineRx (NASDAQ: BLRX) has announced positive top-line results from GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, combined... 
Via Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... 
Via Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
Currency Manipulation
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53. 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Assertio Holdings (NASDAQ:ASRT) stock increased by 19.41% to $0.62 during Thursday's pre-market session. The company's market cap stands at $107.3 million... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.